Pathological Complete Response Rate in Locally Advanced Breast Cancer With FEC, EC-T, or TC as Neoadjuvant Chemotherapy
Clinical trial NCT03349177 · UNKNOWN
Trial details
- NCT number
- NCT03349177
- Sponsor
- Zhiyong Yu
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-27
- Primary completion
- 2019-11-27
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.